These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13902543)

  • 1. [The behavior of blood lipids and cholesterol in chronic glomerulonephritis].
    GUARINI G; MACALUSO M; GALIPO F
    Boll Soc Ital Biol Sper; 1962 Feb; 38():152-4. PubMed ID: 13902543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma lipids in patients with chronic glomerulonephritis].
    Kolmakova EV
    Urol Nefrol (Mosk); 1990; (1):16-9. PubMed ID: 2336751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lipids and lipoproteins in patients with hypertension and chronic glomerulonephritis].
    Kovsh OIa; Pirogova TF; Dundure BL; Guberman SL; Shafro IS
    Vrach Delo; 1985 Feb; (2):61-5. PubMed ID: 3992989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of lipid metabolism in patients with chronic glomerulonephritis].
    Abdurakhmanova SK; Karimova NA
    Pediatriia; 1991; (11):110-1. PubMed ID: 1766730
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypotensive therapy and the level of blood lipids in patients with chronic nephritis associated with arterial hypertension].
    Neverov NI; Kozlova RI; Vinogradova IV; Galstian GM; Shatskaia OB
    Ter Arkh; 1989; 61(6):123-6. PubMed ID: 2799697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism].
    Małyszko JS; Małyszko J; Pawlak K; Myśliwiec M
    Przegl Lek; 1996; 53(8):600-3. PubMed ID: 8999460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis, platelet functions, serotonin and serum lipids during omega-3 fatty acid treatment in patients with glomerulonephritis.
    Malyszko JS; Malyszko J; Pawlak D; Buczko W; Myśliwiec M
    Nephron; 1998 Sep; 80(1):94-6. PubMed ID: 9730718
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of health resort treatment on the south coast of the Crimea on lipid metabolism indices in chronic glomerulonephritis].
    Pyrig LA; Ratner ZG; Vinogradova VS; Shevchenko ZV; Mukhachev NN
    Vrach Delo; 1980 Dec; (12):84-7. PubMed ID: 7222590
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of simvastatin therapy on the lipid blood spectrum and nitric oxide in patients with chronic glomerulonephritis].
    Daminov BT; Raimkulova NP
    Lik Sprava; 2008; (7-8):57-60. PubMed ID: 19663018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between renal biopsy histopathology and profile of changes in serum protein, lipids and proteinuria in patients with nephrotic syndrome due to chronic glomerulonephritis].
    Wiecek A; Kokot F; Strzelczyk P; Witkowicz J; Karkoszka H; Chudek J; Irzyniec T; Klimek D
    Pol Arch Med Wewn; 1993 Dec; 90(6):426-32. PubMed ID: 8146046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glyceridemia in glomerular nephropathies].
    CORSINI G
    Rass Fisiopatol Clin Ter; 1954 Sep; 26(9):675-88. PubMed ID: 14372153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dynamics of the lipid fractions of the blood in renal insufficiency in children with diffuse glomerulonephritis].
    Korovina NA
    Pediatriia; 1968 Feb; 47(2):26-9. PubMed ID: 5729977
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in blood levels of lipids and vitamin A, E and carotene in children with glomerulonephritis].
    Israilov AR; Abrarov AA
    Pediatriia; 1987; (6):107-8. PubMed ID: 3658589
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood lipid changes in glomerular kidney diseases and their pathogenesis].
    CORSINI G
    Rass Fisiopatol Clin Ter; 1955 Oct; 27(10):910-32. PubMed ID: 13298024
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of lipids and cyclosporine.
    Morgenstern BZ; Murphy M; Milliner DS
    Transplant Proc; 1994 Feb; 26(1):130. PubMed ID: 8108906
    [No Abstract]   [Full Text] [Related]  

  • 16. [CHRONIC NECROTIC FOCAL GLOMERULONEPHRITIS].
    BERGER J; DE MONTERA H
    J Urol Nephrol (Paris); 1964 Mar; 70():122-6. PubMed ID: 14137732
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipemia in early stages of acute glomerular nephritis.
    HEYMANN W; WILSON SG
    J Clin Invest; 1959 Jan; 38(1, Part 1):186-92. PubMed ID: 13620781
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the serum lipid spectrum of glomerulonephritis patients].
    Nikulina GG; Petrun' NM; Pyrig LA; Mel'man NIa
    Vrach Delo; 1985 Oct; (10):20-4. PubMed ID: 4090424
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in lipid metabolism in the evolution of glomerulonephritis].
    Pyrig LA; Mel'man NIa; Anishenko VM
    Vrach Delo; 1981 Aug; (8):85-8. PubMed ID: 7269519
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nefroprotective influence of the Comarum palustre L. on chronic experimental glomerulonephritis].
    Mondodoev AG; Bikmulina GA; Razuvaeva IaG; Azhunova TA; Khobrakova VB; Ferubko EV
    Patol Fiziol Eksp Ter; 2010; (1):24-7. PubMed ID: 20731125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.